Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04263532 · ClinicalTrials.gov registry record
Vector Efficacy Cross-Over Pilot Study
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Terminated
- Registry status
- 21
- Enrollment target
NCT04263532: Clinical Trial study, sponsored by Philips Clinical & Medical Affairs Global.
NCT04263532 is a clinical trial that was terminated before completion, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04263532 was terminated before completion, sponsored by Philips Clinical & Medical Affairs Global.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The study evaluates the safety and efficacy of the modified Bi-level positive airway pressure (BiPAP) A40 with Vector Algorithm to treat Chronic Obstructive Pulmonary Disease (COPD) patients with excessive carbon dioxide in their bloodstream (hypercapnia) and expiratory flow limitation (EFL), a constriction of the lower airways. The study will include current users of non-invasive ventilation (NIV) as well as those who are not currently using an NIV device.
Primary Outcome
Room air CO2 levels at the end of 4-6 weeks of therapy as determined by Arterial Blood Gas (PaCO2)
Interventions
- DEVICE Modified BiPAP A40 with Vector Algorithm (Vector)
- DEVICE Modified BiPAP A40 with Standard of Care Settings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-01-21 |
| Est. Completion | 2023-11-17 |
Why NCT04263532 stopped before completion
NCT04263532 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Modified BiPAP A40 with Vector Algorithm (Vector) is the first listed.
NCT04263532 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04263532 about?
NCT04263532 is a clinical study titled "Vector Efficacy Cross-Over Pilot Study". The study evaluates the safety and efficacy of the modified Bi-level positive airway pressure (BiPAP) A40 with Vector Algorithm to treat Chronic Obstructive Pulmonary Disease (COPD) patients with excessive carbon dioxide in their bloodstream (hypercapnia) and expiratory flow limitation (EFL), a cons...
What is the current status of trial NCT04263532?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2020-01-21. Estimated completion is 2023-11-17.
What interventions are being tested in trial NCT04263532?
The interventions under investigation include: Modified BiPAP A40 with Vector Algorithm (Vector) (DEVICE), Modified BiPAP A40 with Standard of Care Settings (DEVICE).
Who is sponsoring clinical trial NCT04263532?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI